Leuprolide Acetate Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting Oct 20, 2026 · last update Oct 20, 2026
Manufacturers: Amneal Pharmaceuticals
Stated reasons (per FDA): Not stated (FDA did not give a reason)
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Leuprolide Acetate, Injection, 14 mg/2.8 mL (1 mg/0.2 mL) (NDC 70121-2537-6) | Amneal Pharmaceuticals | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted Oct 20, 2026 Updated Oct 20, 2026 Discontinued Oct 20, 2026 |